A Pilot Study to Investigate if Frequency of Therapy Alters Outcomes of the Lee Silverman Voice Treatment (LSVT) Programme for Patients with Parkinson's Disease
| ISRCTN | ISRCTN40910122 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN40910122 |
| Protocol serial number | N0016131978 |
| Sponsor | Department of Health |
| Funder | Hammersmith Hospital NHS Trust (UK) |
- Submission date
- 30/09/2004
- Registration date
- 30/09/2004
- Last edited
- 07/09/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Ms Deirdre Cotter
Scientific
Scientific
Department of Speech and Language Therapy
Hammersmith Hospital
Du Cane Road
London
W12 0HS
United Kingdom
| Phone | +44 (0)208 383 3076 |
|---|---|
| abc@email.com |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | A Pilot Study to Investigate if Frequency of Therapy Alters Outcomes of the Lee Silverman Voice Treatment (LSVT) Programme for Patients with Parkinson's Disease |
| Study objectives | A Pilot Study to Investigate if Frequency of Therapy Alters Outcomes of the Lee Silverman Voice Treatment (LSVT) Programme for Patients with Parkinson's Disease |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Nervous System Diseases: Parkinson's disease |
| Intervention | Not provided at time of registration |
| Intervention type | Other |
| Primary outcome measure(s) |
Publication |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 10/01/2005 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 27 |
| Key inclusion criteria | 1. Patients entering the study will have volunteered for the study and will have agreed to be randomly allocated to either a control group or one of two treatment groups. 2. A diagnosis of idiopathic PD 3. Categorised between stages 1 to 4 on the `Functional Rating Scale for Parkinson's Disease¿, Hoehn & Yahr (1967) 4. Neuropharmacologically stable before and during treatment 5. Fluent English speakers 6. Intelligibility of speech will have received a rating of between 5 and 9 on the Parkinson¿s disease disability rating scale. (Yorkston 1995) |
| Key exclusion criteria | 1. Any history of a language deficit caused by a past event such as a cardiovascular event 2. Evidence of a cognitive deficit on the `Mini-Mental State Examination (score >24), Folstein et al 1975 3. Evidence of depression on the Beck Depression inventory (score <14), Beck & Beck 1972. 4. History of a chronic hearing loss or report/suspected hearing loss 5. History of laryngeal disease and will be free of acute cardiac and respiratory conditions during the study |
| Date of first enrolment | 08/08/2003 |
| Date of final enrolment | 10/01/2005 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Hammersmith Hospital
London
W12 0HS
United Kingdom
W12 0HS
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
